Bactroban and Primary pulmonary hypertension - a phase IV clinical study of FDA data

Summary:

Primary pulmonary hypertension is reported as a side effect among people who take Bactroban (mupirocin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Lipitor, and have Pulmonary hypertension.

The phase IV clinical study analyzes which people have Primary pulmonary hypertension when taking Bactroban. It is created by eHealthMe based on reports of 4,919 people who have side effects when taking Bactroban from the FDA, and is updated regularly.

What is Bactroban?

Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,967 Bactroban users. Check the latest studies of Bactroban.

What is Primary pulmonary hypertension?

Primary pulmonary hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart) is found to be associated with 731 drugs and 849 conditions by eHealthMe. Check the latest studies of Primary pulmonary hypertension.

On Feb, 13, 2026

4,919 people reported to have side effects when taking Bactroban.
Among them, 14 people (0.28%) have Primary pulmonary hypertension.

Could Bactroban cause Primary pulmonary hypertension?

Among these 14 people:

How long have people been on Bactroban when they have Primary pulmonary hypertension? *

What is the gender of people who have Primary pulmonary hypertension when taking Bactroban? *

female: 21.43 %
male: 78.57 %

What is the age of people who have Primary pulmonary hypertension when taking Bactroban? *

What are other drugs people take besides Bactroban? *

What are other side effects people have besides Primary pulmonary hypertension? *

Oedema Peripheral (superficial swelling): 10 people, 71.43%
Dyspnea (difficult or laboured breathing): 9 people, 64.29%
Fatigue (feeling of tiredness): 8 people, 57.14%
Pulmonary Oedema (fluid accumulation in the lungs): 8 people, 57.14%
Cardiac Failure Congestive: 8 people, 57.14%
Chest Pain: 7 people, 50.00%
Pain: 7 people, 50.00%
Nausea (feeling of having an urge to vomit): 7 people, 50.00%
Weakness: 6 people, 42.86%
Joint Pain: 6 people, 42.86%

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 8 people, 57.14%
Stress And Anxiety: 3 people, 21.43%
Cough: 3 people, 21.43%
Oedema Peripheral (superficial swelling): 2 people, 14.29%
Upper-Airway Cough Syndrome: 2 people, 14.29%
Pain: 2 people, 14.29%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 14.29%
Cardiac Failure Congestive: 1 person, 7.14%
Constipation: 1 person, 7.14%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Bactroban and have Primary pulmonary hypertension?

- Check whether Primary pulmonary hypertension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bactroban:

Bactroban (4,967 reports)

Browse all side effects of Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Primary pulmonary hypertension:

Primary pulmonary hypertension (731 drugs)

Browse all the conditions that are associated with Primary pulmonary hypertension:

Primary pulmonary hypertension (849 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mupirocin (the active ingredients of Bactroban) and Bactroban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.